Sun Pharma Advanced Research Company share news, announcements and annual reports
NSE: SPARCBSE: 532872Pharmaceuticals & BiotechnologySmall Cap
Sun Pharma Advanced Research Company Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2007
Last close ₹182.98up ₹0.32 (0.18%)BSE ₹183.25
Share price at the NSE close on 29 Oct 2026. Previous close ₹182.66.
29 Oct: open ₹182.66, high ₹184.90, low ₹180.50
52-week range of traded prices to 29 Oct 2026
₹108.00Low, 23 Mar 2026₹289.00High, 8 Jul 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,938 Cr778th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 3.74
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 118.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 84.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,32,78137.7% delivered
Sun Pharma Advanced Research Company orders, deals and press releases
83 filed, newest first. Page 2 of 2.
Mar 2019
Jan 2019
Dec 2018
Nov 2018
Sep 2018
Aug 2018
Jul 2018
Dec 2017
Oct 2017
Jul 2017
Jun 2017
May 2017
Jul 2016
Apr 2016
Sep 2015
Aug 2015
Jun 2015
Mar 2015
Dec 2014
Feb 2014
Jan 2014
Dec 2013
May 2013
Mar 2013
Oct 2012
4 Oct · Business
Pursuant the Rights Issue of Equity Shares of the Company, 29588056 Equity Shares of the Company of Re.1 each, partly paid upto the extent of Re. 0.60/- are to be issued and allotted to 13067 allotees who have applied for Equity Shares of the Company. Accordingly, the Fund Mobilising Committee of the Company at its meeting held on October 03, 2012 has allotted 29,588,056 (Two Crore Ninety Five Lac Eighty Eight Thousand and Fifty Six) Equity Shares of Re.1/- each, partly paid upto the extent of Re.0.60/- bearing Distinctive Nos From 207116392 to 236704447 to the 13067 allotees who have applied for Equity Shares of the Company Consequently, the paid up Equity Share Capital of the Company has increased from Rs.207116391 to Rs.224869224.60 as of date.
Apr 2012
Jun 2011
Jun 2010
May 2010